Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Brazil pushes diabetes early detection:

This article was originally published in Clinica

Executive Summary

Brazil today set out how its more than 26,000 family healthcare teams are to put the early diagnosis of diabetes at the top of their agenda. The first national guidelines for the integral management of diabetes in the national health system (SUS), published to mark World Diabetes Day, also aim to address the healthcare needs of the country's estimated 5.5 million diabetics. The condition affects around 11% of people aged over 40. "The incidence is rising and already accounts for 15% of all national healthcare spending," noted the health ministry.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT053501

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel